IL4-Receptor-Targeted Dual Antitumoral Apoptotic Peptide-siRNA Conjugate Lipoplexes
ADVANCED FUNCTIONAL MATERIALS
Authors: Luo, Jie; Hoehn, Miriam; Reinhard, Soeren; Loy, Dominik M.; Klein, Philipp Michael; Wagner, Ernst
Abstract
Targeted delivery remains the major limitation in the development of small interfering RNA (siRNA) therapeutics. The successful siRNA multistep delivery requires precise carriers of substantial complexity. To achieve this, a monodisperse carrier is presented, synthesized by solid-phase supported chemistry. The sequence-defined assembly contains two oleic acids attached to a cationizable oligoaminoamide backbone in T-shape configuration, and a terminal azide functionality for coupling to the atherosclerotic plaque-specific peptide-1 (AP-1) as the cell targeting ligand for interleukin-4 receptor (IL-4R) which is overexpressed in a variety of solid cancers. For combined cytosolic delivery with siRNA, different apoptotic peptides (KLK, BAK, and BAD) are covalently conjugated via bioreversible disulfide linkage to the 5 '-end of the siRNA sense strand. siRNA-KLK conjugates provide the highest antitumoral potency. The optimized targeted carrier is complexed with dual antitumoral siEG5-KLK conjugates. The functionality of each subdomain is individually confirmed. The lipo-oligomer confers stable assembly of siRNA conjugates into spherical 150-250 nm sized nanoparticles. Click-shielding with dibenzocyclootyne-PEG-AP-1 (DBCO-PEG-AP-1) mediates an IL-4R-specific cell targeting and gene silencing in tumor cells. Most importantly, formulation of the siEG5-KLK conjugate displays enhanced apoptotic tumor cell killing due to the combined effect of mitotic arrest by EG5 gene silencing and mitochondrial membrane disruption by KLK.
IL-4 and serum amyloid P inversely regulate fibrocyte differentiation by targeting store-operated Ca2+ channels
PHARMACOLOGICAL REPORTS
Authors: Zhong, Jin-nan; Lan, Lan; Chen, Yi-fei; Huang, Ge; He, Guang-zhen; Yang, Jiong; Gao, Ya-dong
Abstract
Background: Circulating fibrocytes (CFs) have been shown to participate in subepithelial fibrosis of asthma with chronic airflow limitation by acting as an important source of fibroblasts deposited beneath airway epithelia. Serum amyloid P (SAP) is an innate inhibitor of fibrocytes differentiation. Store-operated Ca2+ entry (SOCE) is the major Ca2+ influx of non-excitable cells. In this study, the role of SOCE in the regulation of fibrocytes differentiation and the effects of Th2 cytokine IL-4 and SAP on SOCE of fibrocytes were investigated. Methods: Peripheral blood mononuclear cells or monocytes were cultured in serum-free medium for 7 days to differentiate into fibrocytes; the expression of SOC channels was determined with PCR, SOCE was measured with Ca2+ fluorescence imaging. Results: IL-4 significantly promoted monocyte derived fibrocytes differentiation in vitro. It also increased both SOCE which was induced by thapsigargin or UTP and molecules STIM1 and Orai1 which were related to expression of SOC channels in fibrocytes. Fibrocytes differentiation induced by IL-4 and SOC channels activity could be inhibited by SOC channel blocker SKF-96365. As expected, SAP significantly inhibited IL4-induced differentiation of fibrocytes, the activity of SOCE and the expression of STIM1 and Orai1 in IL-4-treated fibrocytes. Conclusion: IL-4 and SAP reversely regulates cultured fibrocytes differentiation in vitro by respectively promoting or inhibiting the expression and activity of SOC channels in fibrocytes. (c) 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o. o. All rights reserved.